262 related articles for article (PubMed ID: 742286)
1. Arachidonic acid-induced platelet aggregation and thromboxane A2 generation in patients with coronary heart disease.
Szczeklik A; Gryglewski RJ; Musiał J; Grodzínska L; Serwónska M; Wójcik-Switek L; Marcinkiewicz E
Acta Biol Med Ger; 1978; 37(5-6):741-2. PubMed ID: 742286
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane generation and platelet aggregation in survivals of myocardial infarction.
Szczeklik A; Gryglewski RJ; Musiał J; Grodzińska L; Serwońska M; Marcinkiewicz E
Thromb Haemost; 1978 Aug; 40(1):66-74. PubMed ID: 725852
[TBL] [Abstract][Full Text] [Related]
3. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
Heinroth I; Block HU; Mest HJ
Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
[TBL] [Abstract][Full Text] [Related]
4. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
Block HU; Förster W; Heinroth I
Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
[TBL] [Abstract][Full Text] [Related]
5. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane biosynthesis in platelets of diabetic and coronary artery diseased patients.
Butkus A; Shirey EK; Schumacher OP
Artery; 1982; 11(3):238-51. PubMed ID: 7184495
[TBL] [Abstract][Full Text] [Related]
7. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
8. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
Mevkh AT; Basevich VV; Varfolomeev SD
Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
[TBL] [Abstract][Full Text] [Related]
10. Testosterone potentiation of ionophore and ADP induced platelet aggregation: relationship to arachidonic acid metabolism.
Pilo R; Aharony D; Raz A
Thromb Haemost; 1981 Aug; 46(2):538-42. PubMed ID: 6795741
[TBL] [Abstract][Full Text] [Related]
11. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Mazurov AB; Leĭtin VL; Repin VS
Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
13. Decreased platelet aggregation but increased thromboxane A2 generation in polycythemia vera.
Mehta P; Mehta J; Ross M; Ostrowski N; Player D
Arch Intern Med; 1985 Jul; 145(7):1225-7. PubMed ID: 4015270
[TBL] [Abstract][Full Text] [Related]
14. Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis.
Laffi G; Cominelli F; La Villa G; Fedi S; Pinzani M; Meacci E; Gentilini P
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():366-9. PubMed ID: 2959079
[No Abstract] [Full Text] [Related]
15. The role of thromboxane A2 in endotoxin-induced aggregation of guinea-pig platelets in vitro.
Bult H; Herman AG
Agents Actions Suppl; 1979; (4):147-55. PubMed ID: 386740
[TBL] [Abstract][Full Text] [Related]
16. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
17. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
Rao AK; Willis J; Holmsen H
J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
[TBL] [Abstract][Full Text] [Related]
18. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
Heinroth I; Förster W
Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
[No Abstract] [Full Text] [Related]
19. Residual cyclooxygenase-1 activity and epinephrine reduce the antiplatelet effect of aspirin in patients with acute myocardial infarction.
Moscardó A; Santos MT; Fuset MP; Ruano M; Vallés J
Thromb Haemost; 2011 Apr; 105(4):663-9. PubMed ID: 21301784
[TBL] [Abstract][Full Text] [Related]
20. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
Grodzińska L; Marcinkiewicz E
Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
